Blenrep 100 mg lyophilized powder for injection Images
Generic Name: belantamab mafodotin
This medication has been identified as Blenrep 100 mg lyophilized powder for injection. It is supplied by GlaxoSmithKline.
Blenrep is used in the treatment of Multiple Myeloma and belongs to the drug class miscellaneous antineoplastics. Blenrep 100 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Blenrep
- Generic Name
- belantamab mafodotin
- Strength
- 100 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Miscellaneous antineoplastics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- GlaxoSmithKline
- National Drug Code (NDC)
- 00173-0896
More about Blenrep (belantamab mafodotin)
- Check interactions
- Compare alternatives
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.